Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor.
J Med Chem
; 62(19): 8711-8732, 2019 10 10.
Article
in En
| MEDLINE
| ID: mdl-31532644
Full text:
1
Database:
MEDLINE
Main subject:
Receptors, Dopamine D1
/
Isoquinolines
Limits:
Animals
/
Humans
Language:
En
Year:
2019
Type:
Article